Is the dawn of a new era for Alzheimer's treatment finally here?
As Biogen & Eisai’s Aβ antibody therapies inch closer to approval in Taiwan, the Alzheimer’s treatment race is heating up again — but that’s not all…
In the latest #Globalbio Cover Story (Vol. 125), we spotlight 6 Taiwanese companies charging into clinical trials with innovative mechanisms — from neurorepair to anti-inflammatory strategies — pushing past the traditional Aβ targets.
Plus: With new global diagnostic standards for 2024, 7 rising Taiwanese Medtech players are revolutionizing early detection of Alzheimer’s, leading the way in tackling dementia head-on!
Taiwan isn’t just catching up — it’s trailblazing its own path in the fight against neurodegeneration.
Read the full story now:
https://news.gbimonthly.com/tw/magazine/show2.php?num=162
#TaiwanBiotech #AlzheimersAwareness #NeuroScience #InnovationInHealth #EarlyDetection #BrainHealth #ClinicalTrials #Globalbio — follow us for more biomedical breakthroughs!